Dermatology Consultants

CLIA Laboratory Citation Details

2
Total Citations
9
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 45D0686795
Address 9 Medical Parkway Plaza 4 Suite # 105, Dallas, TX, 75234
City Dallas
State TX
Zip Code75234
Phone(972) 243-4530

Citation History (2 surveys)

Survey - April 1, 2025

Survey Type: Standard

Survey Event ID: IUSJ11

Deficiency Tags: D5217 D5217 D0000

Summary:

Summary Statement of Deficiencies D0000 The laboratory was found to be in substantial compliance with CLIA regulations 42 CFR Part 493. Standard level deficiency cited. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on surveyor observation, review of twice annual accuracy assessments of Potassium Hydroxide (KOH) testing in 2023, and confirmed in interview, the laboratory failed to document two of two annual accuracy assessments of KOH testing in 2023. Findings Included: 1. During a tour of the facility on 04/01/2025 at 10:15 AM, the surveyor observed one bottle of KOH reagent available for patient testing in the microscope area. 2. Review of facility twice annual accuracy assessments of Potassium Hydroxide (KOH) testing in 2023, revealed no documentation of the laboratory performing two of two assessments in 2023. The surveyor requested the above documentation, and none was provided. 3. In an interview on 04/01/2025 at 09: 48 AM in the facility breakroom, the laboratory histotechnician confirmed the above findings. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 28, 2020

Survey Type: Standard

Survey Event ID: I4BC11

Deficiency Tags: D0000 D5391 D5417 D0000 D5391 D5417

Summary:

Summary Statement of Deficiencies D0000 The Histotech was at the entrance conference conducted 01/28/2020. The survey process was discussed. An opportunity for questions and comments was given. Exit conference was held with the Histotech on 01/28/2020. The laboratory was found to be in substantial compliance for the specialties/subspecialties for which it was surveyed. The standard level deficiencies cited were discussed. The process for submitting the corrections was explained. D5391 PREANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1249(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems specified at 493.1241 through 493.1242. This STANDARD is not met as evidenced by: Based on review of the potassium hydroxide (KOH) patient log, patient charts, laboratory's annual test volume, and in interview with staff, the laboratory failed to ensure their policies and procedures were effective for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems for KOH tests. Findings included: 1. Review of the KOH patient log from 10 /2017 through 01/2020 included dates of service, patient names, physician last name initial, patient chart number, specimen source, KOH type, and results. 2. Random sampling of 4 patient charts that included KOH results were selected for review. In the sampling, 1 of 4 patient chart numbers was inaccurately documented in the KOH log, as follows: The log had documented, "11/01/2019; [Patient Name]; [Physician Initial]; 230001 (patient chart number); L (left) hand; M (mycology); - (negative)." Review of the patient chart with this patient's name included a chart number of 922690, not 230001. The chart did not include a description of a left hand, it included a description of a right hand with KOH negative results. The chart included a visit date of 11/01/2019 and time of 10:10 am. 3. The laboratory was asked to provide the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- patient's chart with the chart number 230001 and it included a visit date/time of 11/01 /2019 at 10:30 am. The chart included assessment of the left buttock and did not include a KOH result. The laboratory did not ensure accurate documentation of patient chart numbers when performing a KOH test. The laboratory's policies and procedures were not effective for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems for KOH tests. 4. Review of the laboratory's annual volume included 89 KOH tests. 5. During an interview on 01/28/2020 at 10:25 am, the Histotech reviewed and confirmed the above findings. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on direct observation, laboratory annual test volume, and in interview with staff, the laboratory failed to ensure reagents used for histopathology procedures had not exceeded their expiration dates. Findings included: 1. During a tour of the laboratory on 01/28/2020 at 9:51 am, the following reagents were observed to be stored on the counter and in-use: Submount (1 pint), Lot #7214, expiration date 07/14 /2019 Red Margin Marker (Tissue Marking Dye), Lot #26738, expiration date 09 /2015 Blue Margin Marker (Tissue Marking Dye), Lot #26953, expiration date 10 /2015 Black Tissue Marking Dye, Lot #057300, expiration date 08/2019 The laboratory did not ensure the above items had not exceeded their expiration date. 2. Review of the laboratory's annual volume included 170 histopathology tests. 3. During an interview on 01/28/2020 at 10:25 am, the Histotech confirmed the above findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access